FindTrial
Sign In

Lumber Puncture

PROCEDURE3 trials

Sponsors

National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, Sabine Mueller, MD, PhD

Conditions

Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNSGlioblastomaGranulomatosis, LymphomatoidLymphomatoid GranulomatosisLymphoproliferative DisorderNon-Hodgkins LymphomaRecurrent Atypical Teratoid/Rhabdoid Tumor

Phase 2

Treatment and Natural History Study of Lymphomatoid Granulomatosis
CompletedNCT00001379
National Cancer Institute (NCI)Granulomatosis, Lymphomatoid, Lymphomatoid Granulomatosis, Lymphoproliferative Disorder +1
Start: 1995-05-05End: 2025-01-17Updated: 2025-06-19
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Not yet recruitingNCT07447076
Sabine Mueller, MD, PhDAtypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS, Recurrent Atypical Teratoid/Rhabdoid Tumor
Start: 2026-05-01End: 2036-12-31Target: 29Updated: 2026-03-03

Unknown Phase

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
WithdrawnNCT05927610
Memorial Sloan Kettering Cancer CenterGlioblastoma
Start: 2023-06-19End: 2024-02-15Updated: 2025-05-21

Related Papers

Effectiveness of Immunotherapy in Treating Lymphomatoid Granulomatosis
Oncology Times2023-07-10
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial.
2023-03-317 citations